| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 10/05/2011 | EP1920786B1 Oral preparation for measuring pyrimidine metabolic capacity |
| 10/05/2011 | CN102206306A Tumor-targeted carrier material as well as preparation method and application thereof |
| 10/05/2011 | CN102206276A Humanized antibodies derived from DD-3B6/22, specific for the D-dimer fragment of fibrin |
| 10/05/2011 | CN101060865B A method of diagnosing prodromal forms of diseases associated with amyloid deposition |
| 10/04/2011 | US8030458 Monoclonal antibodies to tacrolimus and immunoassays methods for tacrolimus |
| 10/04/2011 | US8030270 Methods for identifying GLP-1 secretagogues |
| 10/04/2011 | US8029985 Amplified bioassay |
| 10/04/2011 | US8029795 treatment of iron overload e.g. from a blood transfusion; an iron chelator, a targeting agent and a lipid carrier, e.g., a liposome; targeting the heart |
| 10/04/2011 | US8029788 Variants of humanized anti-carcinoma MAb CC49 |
| 10/04/2011 | US8029787 Method of diagnosing, monitoring, staging, imaging and treating various cancers |
| 10/04/2011 | US8029764 Isolating an mRNA sample from feces; detecting renal dipeptidase mRNA in the sample; comparing the amount the mRNA in the sample to amounts of renal dipeptidase mRNA in normal subjects, wherein an elevated level indicates colorectal cancer |
| 10/04/2011 | CA2381123C Actinium-225 complexes and conjugates for radioimmunotherapy |
| 09/29/2011 | WO2011119340A1 Smart contrast agent and method for detecting transition metal ions and treating related disorders |
| 09/29/2011 | WO2011117421A1 Tricyclic indole derivatives as pbr ligands |
| 09/29/2011 | WO2011117305A1 Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates |
| 09/29/2011 | WO2011070212A3 Multifunctional nanostructures as trimodal mri/oi/spect diagnosis agents |
| 09/29/2011 | WO2011070203A3 Multifunctional vectorised nanostructures that can be used as trimodal (mri, oi and spect) diagnosis agents |
| 09/29/2011 | WO2011049405A3 Optical imaging contrast agent, use and device thereof |
| 09/29/2011 | US20110239316 ANTI-cMET ANTIBODY |
| 09/29/2011 | US20110236312 Nucleoside analogues useful as positron emission tomography (pet) imaging agents |
| 09/29/2011 | US20110236311 Radiolabelling methods |
| 09/29/2011 | US20110236310 Labeling composition for intraocular tissue, labeling method of intraocular tissue, and screening method |
| 09/29/2011 | US20110236309 Antagonists of ligands and uses thereof |
| 09/29/2011 | US20110236308 Aryl Bidentate Isonitriles and Their Uses |
| 09/29/2011 | US20110236307 In vivo imaging method |
| 09/29/2011 | US20110236305 Methods for protecting and regenerating bone marrow using cxcr3 agonists and antagonists |
| 09/29/2011 | US20110236304 Structural variants of antibodies for improved therapeutic characteristics |
| 09/29/2011 | CA2792394A1 Tricyclic indole derivatives as pbr ligands |
| 09/28/2011 | EP2368580A1 Stabilisation of fluorothymidine precursors |
| 09/28/2011 | EP2368558A1 Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates |
| 09/28/2011 | EP2367851A1 Antibody-targeted carrier for contrast agents |
| 09/28/2011 | EP2367816A1 Isatin derivatives for use as in vivo imaging agents |
| 09/28/2011 | EP2367576A2 Method for the production of scaffolds for tissue engineering, comprising the use of an anchoring unit, and scaffold produced therewith |
| 09/28/2011 | CN102203614A Imaging techniques |
| 09/28/2011 | CN101574531B <99>Tc<m>O nucleus marked ciprofloxacin dithiocarbamate complex and preparation method and applications thereof |
| 09/28/2011 | CN101474415B RGD polypeptide radiopharmaceutical for integrin alphav beta3 positive tumor and preparation method thereof |
| 09/27/2011 | USRE42748 Oral DTPA for radionuclide chelation |
| 09/27/2011 | US8025883 Antagonists and methods for inhibiting angiogenesis |
| 09/27/2011 | US8025865 Carbonic anhydrase (CA); enhance the efficacy of weak base chemotherapeutic drugs; positively charged sulfonamides that have membrane impermeability |
| 09/27/2011 | CA2443273C Tc and re labeled radioactive glycosylated octreotide derivatives |
| 09/22/2011 | WO2011116237A1 Universal cell-directed theranostics |
| 09/22/2011 | US20110230662 Radiolabelled fluorobenzamide analogues, their synthesis and use in diagnostic imaging |
| 09/22/2011 | US20110229410 Technetium-dipyridine complexes, and methods of use thereof |
| 09/22/2011 | US20110229409 Linkable lewis x analogs |
| 09/22/2011 | US20110229408 Sodium-iodide symporter gene repressor binding site |
| 09/22/2011 | US20110229407 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof |
| 09/22/2011 | US20110229406 Material and methods for treating or preventing HER-3 associated diseases |
| 09/22/2011 | DE102010006434B4 Verfahren und Vorrichtung zur Produktion eines 99mTc-Reaktionsprodukts Method and apparatus for production of a reaction product 99mTc |
| 09/22/2011 | CA2792611A1 Affinity peptides toward bmp-2 |
| 09/21/2011 | EP2366693A1 Nitroimidazole-amino acid compound type nuclide hypoxia imaging agent and intermediates for preparing them |
| 09/21/2011 | EP2365974A1 Fluorinated benzothiazole derivatives, preparation method thereof and imaging agent for diagnosing altzheimer's disease using the same |
| 09/21/2011 | EP1531873B1 Agent delivery particle |
| 09/21/2011 | CN102197036A New benzofurans suitable as precursors to compounds that are useful for imaging amyloid deposits |
| 09/21/2011 | CN102196773A Molecular imaging |
| 09/21/2011 | CN102188725A Telomerase-developing-based tumor diagnostic reagent kit |
| 09/21/2011 | CN102188724A Novel ultrasonic quick-release preparation for radiotherapy of tumor in vivo, and preparation method thereof |
| 09/20/2011 | US8022034 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
| 09/20/2011 | US8021644 Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis |
| 09/20/2011 | CA2183542C Methods and compositions for stimulating bone cells |
| 09/15/2011 | WO2011112921A2 Sparc angiogenic domain and methods of use |
| 09/15/2011 | WO2011111698A1 MONOCLONAL ANTIBODY AGAINST NECROSIS MARKER ERp29 AND USE THEREOF |
| 09/15/2011 | WO2011110490A1 Process for the production of radioactively labelled scfv antibody fragments, kits and compositions |
| 09/15/2011 | US20110223645 Multivalent Carriers of Bi-Specific Antibodies |
| 09/15/2011 | US20110223203 Nanocluster compositions and methods |
| 09/15/2011 | US20110223103 Multimodal Imaging of Atherosclerotic Plaque Targeted to LOX-1 |
| 09/15/2011 | US20110223102 Multimodality agents for tumor imaging and therapy |
| 09/15/2011 | CA2792667A1 Sparc angiogenic domain and methods of use |
| 09/14/2011 | CN102186844A Radiolabelled inhibitors of the glycine 1 transporter |
| 09/14/2011 | CN102186505A Imaging and radiotherapy methods |
| 09/14/2011 | CN102180949A Polypeptide capable of specifically combining vessel endothelial growth factor and application thereof |
| 09/14/2011 | CN102180780A Indenone derivative and applications thereof as developing agent and aggregation inhibitor of amyloid protein deposit and neurofibrillary tangle |
| 09/13/2011 | US8017736 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof |
| 09/13/2011 | US8017733 Covalent attachment of hydrophilic polymers, such as polyalkylene glycol polymers, also known as polyalkylene oxides, to biologically-active molecules |
| 09/13/2011 | US8017105 Diagnostic imaging contrast agents with extended blood retention |
| 09/13/2011 | US8017102 Toxins and radionuclides coupled to IGF-1 receptor ligands for treatment of cancer |
| 09/09/2011 | WO2011106847A1 Sorbent material |
| 09/09/2011 | CA2791751A1 Sorbent material |
| 09/08/2011 | US20110217720 Compositions and Kits Pertaining to Analyte Determination |
| 09/08/2011 | US20110217236 Radiation sensitive liposomes |
| 09/08/2011 | US20110217234 Imaging ligands |
| 09/08/2011 | US20110217233 Modulation of intracellular signaling |
| 09/08/2011 | US20110217232 Method for Determination of the Responsiveness of an Individual to Misletoe Lectin |
| 09/08/2011 | US20110217231 Anti-tenascin monoclonal antibody therapy for lymphoma |
| 09/07/2011 | EP2363404A2 PSMA antibodies |
| 09/07/2011 | EP2363392A1 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques |
| 09/07/2011 | EP2363391A1 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques |
| 09/07/2011 | EP2363022A2 Use of oxygen antagonists for the therapeutic treatment of mammals |
| 09/07/2011 | CN102176924A Paramagnetic biomolecule complexes and uses thereof in the assessment of organ function |
| 09/07/2011 | CN101538284B Preparation method and application of 99Tcm-EDTA-MTI coordination compound |
| 09/07/2011 | CN101418020B <99m>Tc marked dimercapto succinate metronidazole esters complex and preparation method and use |
| 09/07/2011 | CN101417939B Method for preparing caprylic-1-<13>C |
| 09/06/2011 | US8012945 Single chain fragment variable (scFv) antibody or an Fab antibody; screening phage-displayed antibodies for an ability to bind to a radiation-inducible neoantigen present on a cell |
| 09/06/2011 | US8012455 Radioactive source materials formable into various shapes |
| 09/06/2011 | US8012454 Embolization |
| 09/06/2011 | CA2519946C Temporary embolization using inverse thermosensitive polymers |
| 09/01/2011 | WO2011106732A1 Pet monitoring of ab-directed immunotherapy |
| 09/01/2011 | WO2011105520A1 Composite body for antigen or drug delivery |
| 09/01/2011 | US20110213293 Ligands to radiation-induced molecules |
| 09/01/2011 | US20110212026 Butyrylcholinesterase ligands as diagnostic tools and treatment for deseases of the nervous system |
| 09/01/2011 | US20110212025 Tspo-targeting compounds and uses thereof |